259
landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels
The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for ,
,
+ Read More
landing page
Frontotemporal Dementia
Frontotemporal Dementia
Frontotemporal dementia (FTD) describes brain conditions characterized by p
rogressive degeneration of the brain’s frontal and temporal lobes., About the Kissick Family Foundation FTD Grant Program
The Kissick Family Foundation partnered with MI Philanthropy’s Science and Health team in 2022 to analyze and understand the state of the FTD research ecosystem and identify where phi,
, Please
+ Read More
landing page
Livestream | 2023 Future of Health Summit
Looking for a session? Scroll down this page to find it. Looking for Program details? Find them
here.
+ Read More
landing page
Science Philanthropy Accelerator for Research and Collaboration
Who We Are
$30 billion in philanthropic funds are spent annually to advance medical research for tr
eatments and cures., Partner with Us
Leverage our strategic advisory service, scientific experts, and the breadth of the Milken Institute network to ensure your philanthropic resources advance medical solutions.
+ Read More
landing page
Center for Public Health Advisory Board
Paul Chew
President, 1Rx DigiPharm Advisory, LLC
report
Giving Smarter: Philanthropic Opportunities to Advance Bipolar Disorder Research
People of all ages, ethnicities, and backgrounds endure the intense shifts in mood and energy level
s bipolar disorder (BD) causes.
+ Read More
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes t
o mind. However, technology and devices are proving to be valuable options for treating intractable illnesses.
+ Read More
report
Sarcoidosis: A Giving Smarter Guide
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have release
d a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis.
+ Read More
report
Alzheimer's Disease - A Giving Smarter Guide
Alzheimer’s disease is increasingly in the spotlight after a number of high-profile clinical trial
failures—an alarming trend as an estimated 5.5 million adult Americans live with this disease, which disproportionally affects the aged population.
+ Read More